Active — Not RecruitingNot Applicable

Augmenting Urinary Reflex Activity: Study 3

Belgium12 participantsStarted 2025-01-15

Plain-language summary

AURA-3 study (Augmenting Urinary Reflex Activity Study 3) is a single arm, short-duration (8 month) cohort follow up study of preceding interventional medical device study, AURA-2.

Who can participate

Age range18 Years – 75 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participant has exited the AURA-2 clinical investigation. * Participant has an implanted Amber UI system. * Consents to participation. Exclusion Criteria: * Participant has withdrawn from AURA-2 clinical investigation. * Participant is pregnant. * A past or current condition that in the opinion of the PI contraindicates enrolment (PI discretion).

What they're measuring

Change in absolute recharge performance

Timeframe: 48 hours; 2 weeks; 2 months; 2 months + 1 week; 4 months; 8 months

Change in relative recharge performance

Timeframe: 48 hours; 2 weeks; 2 months; 2 months + 1 week; 4 months; 8 months

Trial details

NCT IDNCT06597994

SponsorAmber Therapeutics Ltd

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-01

View on ClinicalTrials.gov More Urinary Incontinence trials